JP2001501975A - 亢進した細胞取り込みを有する結合ペプチド核酸 - Google Patents

亢進した細胞取り込みを有する結合ペプチド核酸

Info

Publication number
JP2001501975A
JP2001501975A JP11500871A JP50087199A JP2001501975A JP 2001501975 A JP2001501975 A JP 2001501975A JP 11500871 A JP11500871 A JP 11500871A JP 50087199 A JP50087199 A JP 50087199A JP 2001501975 A JP2001501975 A JP 2001501975A
Authority
JP
Japan
Prior art keywords
naturally occurring
amino acid
side chain
peptide nucleic
group
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP11500871A
Other languages
English (en)
Japanese (ja)
Inventor
ニールセン，ペーター・エー
クヌートセン，ヘレ
Original Assignee
ペーター・エー・ニールセン
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ペーター・エー・ニールセン filed Critical ペーター・エー・ニールセン
Publication of JP2001501975A publication Critical patent/JP2001501975A/ja
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/001—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof by chemical synthesis
    • C07K14/003—Peptide-nucleic acids (PNAs)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/62—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being a protein, peptide or polyamino acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Liposomes
    • A61K9/1271—Non-conventional liposomes, e.g. PEGylated liposomes, liposomes coated with polymers
    • A61K9/1272—Non-conventional liposomes, e.g. PEGylated liposomes, liposomes coated with polymers with substantial amounts of non-phosphatidyl, i.e. non-acylglycerophosphate, surfactants as bilayer-forming substances, e.g. cationic lipids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Molecular Biology (AREA)
  • Virology (AREA)
  • Communicable Diseases (AREA)
  • Biochemistry (AREA)
  • Epidemiology (AREA)
  • Biophysics (AREA)
  • Oncology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Dispersion Chemistry (AREA)
  • AIDS & HIV (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
JP11500871A 1997-05-28 1998-05-28 亢進した細胞取り込みを有する結合ペプチド核酸 Pending JP2001501975A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US86476597A 1997-05-28 1997-05-28
US08/864,765 1997-05-28
PCT/US1998/010804 WO1998053801A1 (en) 1997-05-28 1998-05-28 Conjugated peptide nucleic acids having enhanced cellular uptake

Publications (1)

Publication Number Publication Date
JP2001501975A true JP2001501975A (ja) 2001-02-13

Family

ID=25344022

Family Applications (1)

Application Number Title Priority Date Filing Date
JP11500871A Pending JP2001501975A (ja) 1997-05-28 1998-05-28 亢進した細胞取り込みを有する結合ペプチド核酸

Country Status (7)

Country Link
EP (1) EP1003480A4 (de)
JP (1) JP2001501975A (de)
AU (1) AU745309B2 (de)
CA (1) CA2291839A1 (de)
IL (1) IL133087A0 (de)
NZ (1) NZ501289A (de)
WO (1) WO1998053801A1 (de)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2017518363A (ja) * 2014-05-16 2017-07-06 ウギゼンゼ アーゲーＵｇｉｓｅｎｓｅ Ａｇ ペプチド核酸モノマー及びオリゴマー
JP2017520563A (ja) * 2014-06-24 2017-07-27 シャイアー ヒューマン ジェネティック セラピーズ インコーポレイテッド 核酸の送達のための立体化学的に濃縮した組成物

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6472209B1 (en) 1997-10-17 2002-10-29 Mayo Foundation For Medical Education And Research Using polyamide nucleic acid oligomers to engender a biological response
US6723560B2 (en) 1998-10-08 2004-04-20 Mayo Foundation For Medical Education And Research Using polyamide nucleic acid oligomers to engender a biological response
US6989270B1 (en) 1997-10-17 2006-01-24 Mayo Foundation For Medical Education And Research Using polyamide nucleic acid oligomers to engender a biological response
DE19909373A1 (de) * 1999-03-03 2000-10-05 Ugichem Neue PNA-Monomere, daraus resultierende PNA-Oligomere und deren Verwendung
DE10038169A1 (de) * 2000-08-04 2002-03-07 November Ag Molekulare Medizin Synthetisches Partikel zur Markierung einer Substanz
AU2003260289A1 (en) * 2002-09-11 2004-04-30 Santaris Pharma A/S Modified pna molecules
JP5645840B2 (ja) 2008-12-02 2014-12-24 株式会社Ｗａｖｅ Ｌｉｆｅ Ｓｃｉｅｎｃｅｓ Ｊａｐａｎ リン原子修飾核酸の合成方法
CN102596204B (zh) 2009-07-06 2016-11-23 波涛生命科学有限公司 新的核酸前药及其使用方法
EP2620428B1 (de) 2010-09-24 2019-05-22 Wave Life Sciences Ltd. Asymmetrische hilfsgruppe
JP6128529B2 (ja) 2011-07-19 2017-05-17 ウェイブ ライフ サイエンシズ リミテッドＷａｖｅ Ｌｉｆｅ Ｓｃｉｅｎｃｅｓ Ｌｔｄ． 官能化核酸の合成のための方法
AU2013287630B2 (en) 2012-07-13 2017-05-25 Shin Nippon Biomedical Laboratories, Ltd. Chiral nucleic acid adjuvant
WO2014012081A2 (en) 2012-07-13 2014-01-16 Ontorii, Inc. Chiral control
PL2872485T3 (pl) 2012-07-13 2021-05-31 Wave Life Sciences Ltd. Asymetryczna grupa pomocnicza
WO2015108047A1 (ja) 2014-01-15 2015-07-23 株式会社新日本科学 免疫誘導活性を有するキラル核酸アジュバンド及び免疫誘導活性剤
EP3095460A4 (de) 2014-01-15 2017-08-23 Shin Nippon Biomedical Laboratories, Ltd. Chirales nukleinsäureadjuvans mit antiallergischer wirkung und antiallergikum
JPWO2015108048A1 (ja) 2014-01-15 2017-03-23 株式会社新日本科学 抗腫瘍作用を有するキラル核酸アジュバンド及び抗腫瘍剤
US10160969B2 (en) 2014-01-16 2018-12-25 Wave Life Sciences Ltd. Chiral design
AU2020315947A1 (en) * 2019-07-24 2022-03-10 The Trustees Of Columbia University In The City Of New York Methods and compositions for treating cancer using peptide nucleic acid-based agents
CN114315835B (zh) * 2021-11-30 2023-03-03 华南农业大学 一种6-苯甲基腺嘌呤半抗原、人工抗原、抗体及其制备方法和应用

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK51092D0 (da) * 1991-05-24 1992-04-15 Ole Buchardt Oligonucleotid-analoge betegnet pna, monomere synthoner og fremgangsmaade til fremstilling deraf samt anvendelser deraf
US5539082A (en) * 1993-04-26 1996-07-23 Nielsen; Peter E. Peptide nucleic acids
US5705333A (en) * 1994-08-05 1998-01-06 The Regents Of The University Of California Peptide-based nucleic acid mimics(PENAMS)
ATE222589T1 (de) * 1994-10-06 2002-09-15 Isis Pharmaceuticals Inc Peptid-nukleinsäure-konjugate
AU4344696A (en) * 1994-12-21 1996-07-10 Novartis Ag Oligonucleotide-dendrimer conjugates
EP0870055B1 (de) * 1995-10-12 2007-05-16 LANSDORP, Peter, M. Verfahren zum nachweis von mehrfachkopien einer wiederholungssequenz in einem nukleinsäuremolekül

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2017518363A (ja) * 2014-05-16 2017-07-06 ウギゼンゼ アーゲーＵｇｉｓｅｎｓｅ Ａｇ ペプチド核酸モノマー及びオリゴマー
JP2017520563A (ja) * 2014-06-24 2017-07-27 シャイアー ヒューマン ジェネティック セラピーズ インコーポレイテッド 核酸の送達のための立体化学的に濃縮した組成物

Also Published As

Publication number Publication date
IL133087A0 (en) 2001-03-19
EP1003480A1 (de) 2000-05-31
EP1003480A4 (de) 2002-04-17
NZ501289A (en) 2001-06-29
WO1998053801A1 (en) 1998-12-03
CA2291839A1 (en) 1998-12-03
AU7602198A (en) 1998-12-30
AU745309B2 (en) 2002-03-21

Similar Documents

Publication Publication Date Title
US6686442B2 (en) Conjugated peptide nucleic acids having enhanced cellular uptake
JP2001501975A (ja) 亢進した細胞取り込みを有する結合ペプチド核酸
EP1709195B1 (de) Zelltransfektionsformulierungen von kleiner interferierender rna, verwandte zusammensetzungen und herstellungsverfahren und verwendung
US5777153A (en) Cationic lipids
JP5042863B2 (ja) 生物学的に活性な分子をデリバリーするための脂質ナノ粒子系組成物および方法
JP3941854B2 (ja) 核酸送達用の脂質−ポリアミド結合体および組成物
US20030073640A1 (en) Novel compositions for the delivery of negatively charged molecules
US20030119725A1 (en) Peptide-mediated transfection agents and methods of use
US20030207804A1 (en) Modified peptide nucleic acids
HU223263B1 (hu) Nukleinsavak transzfekciójára alkalmas gyógyászati kompozíciók és alkalmazásuk
JPH11506795A (ja) 脂質及び例えばリポソーム中でのその使用
JP2001517061A (ja) 活性複合体の分離
JP2004501211A (ja) ポリアミド核酸誘導体および薬剤、ならびにその調製方法
MXPA01013114A (es) Conjugados y metodos para la produccion de los mismos, y su uso poara transportar moleculas a traves de membranas biologicas.
EP2596102A2 (de) Sequenzspezifische doppelsträngige dna/rna-bindende verbindungen und ihre verwendung
EP1067969B1 (de) Polyen-makrolidderivate, verwendung zur vektorisierung von molekülen
JP2002510706A (ja) Ｄｎａトランスフェクションのための新規化合物

Legal Events

Date Code Title Description
A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20040212

A602 Written permission of extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A602

Effective date: 20040329

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20040511

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20060425